Back to Rankings

LGND

LigandC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-23
View Chart
Current thesis
The bull case is that Q1 preserved the bigger thesis despite the headline miss: royalty revenue still grew 56% year over year, Filspari received full FDA approval in FSGS and was called Ligand's largest royalty contributor, cash and investments rose to $779.4 million at March 31, 2026, and management reaffirmed the previously raised 2026 guidance tied to XOMA [#8-K-2026-05-07].
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -7.0.
What can break
Ligand remains dependent on partners for regulatory approvals, launch execution, sales conversion, and milestone timing across the royalty portfolio.
Momentum
89
Value
59
Sentiment
20
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $228.00 · Bull $255.00 · Bear $180.00
Data freshness
Prices
As of 2026-07-23
Fundamentals
As of 2026-07-23 • Vendor: Data Vendor v1
Scores
As of 2026-07-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-09 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-23
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $323.30
Why
Momentum89 · Δ7d -7.0
Value59 · Δ7d -0.2
Sentiment20 · Δ7d -2.4
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
89
26% active weight
Current posture
7d trendSoftening
Δ7d
-7.0
Δ21d
-2.5
Value
59
39% active weight
Current posture
7d trendFlat
Δ7d
-0.2
Δ21d
-0.2
Sentiment
20
34% active weight
Current posture
7d trendSoftening
Δ7d
-2.4
Δ21d
-0.7
Why this grade

Composite grade C. Momentum 89.4 / Value 58.9 / Sentiment 19.8

Fundamentals (TTM)
As of 2026-07-23
Market Cap
$6.06B
Beta
1.20
Shares Out
20.04M
P/E (TTM)
92.4
P/S (TTM)
15.04
P/FCF (TTM)
122.87
Rev YoY
+14.1%
EPS YoY
-69.7%
Gross Margin
+83.4%
Op Margin
+7.0%
Net Debt
-$282.03M
Current Ratio
21.28
As of 2026-07-23 • Updated nightlySource: Internal modelMethodology